Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights of Medtronic (MDT) Q4 2020 earnings results
Medtronic plc (NYSE: MDT) reported its financial results for the quarter ended April 24, 2020, on Thursday before the market opens. The results missed analysts’ expectations.
The company posted a 45% dip in earnings for the fourth quarter of 2020 due to the impact of the COVID-19 pandemic. The results were in-line with the expectations and consistent with the impact felt across the MedTech industry from deferred procedures as a result of the pandemic.
Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.
On May 20, the board of directors approved an increase in cash dividend for the first quarter of fiscal 2021, raising the quarterly amount to $0.58 per ordinary share. The dividend is payable on July 17, 2020, to shareholders of record on June 26, 2020.
Past Performance
Most Popular
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the
Constellation Brands set to report Q3 2026 earnings. Here’s what to expect
Constellation Brands' (NYSE: STZ) performance across its portfolio has been under scrutiny recently as it navigates a challenging consumer environment marked by sluggish demand and competitive pressures. With the beer
Broadcom Stock: Valuation and margins under review amid AI tailwinds
Broadcom, Inc. (NASDAQ: AVGO) has emerged as a key AI infrastructure supplier, leveraging its expertise in custom AI accelerators, to expand beyond its legacy smartphone and storage chip businesses. However,
